CareTrust REIT (CTRE)

NYSE Real Estate Health Care REITs S&P MidCap 400
$38.21
+1.03 (+2.77%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+5.0%
1M+6.8%
3M-5.5%
6M-8.2%
YTD+5.7%
1Y+6.1%
3Y+73.8%
5Y+84.1%

Key statistics

Full financials →
Market cap$9.8B
P/E (TTM)23.9
EPS (TTM, diluted)$1.60
P/S580.97
P/B1.85
EV / EBITDA—
Revenue (TTM)$17.00M
Revenue growth-80.5%
Net margin2,148.9%
ROE6.8%
Debt / equity0.39
FCF yield5.1%
Dividend yield3.94%
Payout ratio94%
Beta (1Y)0.06
Volatility (1Y)25.2%
52-week range$34.55 – $43.62
Avg volume (50D)2.47M

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Triple Bottom (weekly)

Forming
CTRE Triple Bottom chart

Trigger $43.62 (+14.2% away). Details →

Nov 5, 4:09 PM ET

CareTrust REIT Reports Q3 2026 Results and Updates Guidance

Positive earnings 2.027.01

CareTrust REIT reported third quarter 2026 net income of $83.7 million, or $0.35 per diluted share, matching the prior year period. The company also announced an increase to its full-year 2026 guidance midpoints for Normalized FFO and Normalized FAD, and reported significant investment activity including the initial closing of 45 U.K. care homes.

  • Net income for the quarter ended September 30, 2026, was $83.7 million, or $0.35 per diluted share.
  • Normalized FFO per diluted share grew 20% year-over-year to $0.54.
  • Full-year 2026 guidance was updated to project Normalized FFO of approximately $2.08 to $2.09 per share.
  • The quarterly dividend was maintained at $0.39 per share.
Read the filing on SEC.gov ↗
Oct 2, 6:00 AM ET

CareTrust closes $764 million UK care home acquisition from LNT and raises 2026 guidance

Positive m&a Written later 2.017.01

On October 1, 2026, CareTrust completed the purchase of 24 completed UK care homes from LNT Care Developments for £576 million (about $764 million), excluding transaction costs. The company also expects to acquire 21 more homes under development for £504 million (about $669 million) on a rolling basis through December 31, 2027, and raised its full-year 2026 guidance, which shareholders may view as a sign of improved earnings expectations.

  • 24 completed care homes acquired October 1, 2026 for £576 million (about $764 million), excluding transaction costs
  • 21 in-development homes to be acquired for £504 million (about $669 million) as they are completed and approved, through December 31, 2027
  • Full-year 2026 guidance raised: net income attributable to CareTrust of $1.54 to $1.57 per share and Normalized FFO of $2.06 to $2.09 per share
  • Initial closing funded by proceeds from settling outstanding forward equity agreements and a draw on the revolving credit facility
Read the filing on SEC.gov ↗
Aug 6, 4:18 PM ET

CareTrust REIT Q2 EPS rises 9% and company raises its 2026 guidance

Positive earnings Written later 2.027.01

CareTrust REIT reported second quarter 2026 net income of $89.0 million, or $0.38 per diluted share, up $0.03 or 9% from a year earlier, and Normalized FFO of $119.7 million, or $0.51 per share, up 19%. The company also issued updated 2026 guidance, projecting Normalized FFO of $2.03 to $2.06 per share, which it says represents a 16.2% increase at the midpoint over 2025.

  • Q2 2026 net income attributable to CareTrust was $89.0 million ($0.38 per diluted share), versus $68.5 million in Q2 2025.
  • Normalized FFO was $119.7 million ($0.51 per diluted share), up 19% from $0.43 a year earlier.
  • 2026 guidance: Normalized FFO of $2.03 to $2.06 per share and Normalized FAD of $2.01 to $2.04 per share, based on 233 million weighted average diluted shares.
  • Quarterly dividend of $0.39 per share was declared; the company reported a Net Debt to Annualized Normalized Run Rate EBITDA ratio of 1.01x as of quarter end.
Read the filing on SEC.gov ↗
May 7, 4:18 PM ET

CareTrust REIT raises 2026 guidance as first-quarter Normalized FFO rises 14%

Positive guidance Written later 2.027.01

CareTrust REIT reported first-quarter 2026 results that improved from a year earlier and raised its full-year 2026 guidance. Normalized FFO was $0.48 per diluted share, up from $0.42, and the company raised its quarterly dividend to $0.39 per share from $0.335. For shareholders, the filing shows higher earnings per share, a larger dividend and higher projected per-share results for 2026.

  • Net income attributable to CareTrust was $80.2 million, or $0.36 per diluted share, versus $0.35 a year earlier.
  • Normalized FFO was $107.4 million, or $0.48 per diluted share, versus $0.42 a year earlier.
  • 2026 guidance: Normalized FFO of $2.00 to $2.04 per share and Normalized FAD of $1.98 to $2.02 per share.
  • Quarterly dividend increased to $0.39 per share from $0.335 per share.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Famous investors who own CTRE

All investors →
InvestorValue% of portfolioLast quarter
George Soros Soros Fund Management $13.13M0.16% New

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Prices are end-of-day and split-adjusted. Financial data from CareTrust REIT's SEC XBRL filings. Not investment advice.